Milnacipran: Difference between revisions
| [unchecked revision] | [pending revision] |
MDElliottMD (talk | contribs) Auto-created stub |
Assign pharmacological categories from List_of_CNS-active_medicines |
||
| (4 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{MedTemplate | {{MedTemplate | ||
| generic | | generic = Milnacipran | ||
| brand | | brand = Savella | ||
| classes | | structure = | ||
| mechanism | | classes = SNRI, Antidepressant | ||
| mechanism = Serotonin–norepinephrine reuptake inhibitor | |||
| uses = | |||
| starting_dose = | |||
| preparations = | |||
| fda_max = | |||
| routes = | |||
| onset = | |||
| duration = | |||
| halflife = | |||
| bioavailability = | |||
| pregnancy = | |||
| legal = | |||
| intro = | |||
| pharmacokinetics = | |||
| pharmacodynamics = | |||
| indications = | |||
| dosing = | |||
| effects = | |||
| interactions = <pharmaInteractions/> | |||
| pregnancy_details = | |||
| monitoring = | |||
| counseling = | |||
| anecdotes = | |||
| seealso = | |||
| references = | |||
}} | }} | ||
[[Category:Serotonin–Norepinephrine Reuptake Inhibitors (SNRIs)]] | |||
[[Category:Antidepressants]] | [[Category:Antidepressants]] | ||
Latest revision as of 15:06, 14 May 2026
SNRI, Antidepressant
Milnacipran
Savella
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Interactions
Fluoxetine via Category:Antidepressants exp n/a/5 outcome n/a (n=1) exp 1.0/5 outcome +33.0 (n=1)
How much experience do you have with this combination (1 a little, 5 a lot)?
How did it go? (-100 worst, +100 best)
- checking this mechanism here
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
SNRI, Antidepressant
Common uses
Pharmacy
Pharmacology
Purported mechanism
Serotonin–norepinephrine reuptake inhibitor